Moderna's total assets for Q3 2025 were $12.13B, an increase of 1.04% from the previous quarter. MRNA total liabilities were $2.81B for the fiscal quarter, a 7.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.